Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030567 (Parkinson's disease)
63,064 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We compared the chronic (2-year) effect of substitution with Sinemet CR with the effect of continued administration of standard Sinemet on motor fluctuations and drug-induced side effects in Parkinson's disease (PD). Twelve patients in each treatment group were pair-matched for age, PD duration, duration of levodopa therapy, dosage of Sinemet, PD disability, and side-effect prevalence at study entry. After 2 years, both groups were more disabled from their PD than at baseline; the disability scores were equivalent for the 2 treatments. The Sinemet CR group had fewer fluctuations and fewer side effects. Compared with the standard Sinemet group, Sinemet CR patients had more "on" time (mean 83% versus 62%, p less than 0.001), and had a lower prevalence of disabling chorea (p less than 0.007), dystonia (p less than 0.003) and sleep disruption (p less than 0.002). Prevalence of hallucinations was equivalent for the 2 groups. These results suggest that Sinemet CR is beneficial in ameliorating and preventing the high frequency of some side effects of standard Sinemet treatment.
...
PMID:Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. 258 64

In 19 patients with severe Parkinson's disease, we replicated the surgical procedures developed by Madrazo et al. for transplantation of the adrenal medulla to the striatum, and followed them for six months after operation. We monitored their motor function with the use of standardized scales and determined the amount and quality of "on" and "off" time (the hours of the waking day when the antiparkinsonian medications were effective and ineffective, respectively). We found significant improvement in focal areas of motor function. The mean percentage of on time during the day increased from 47.6 percent to 75.0 percent (P = 0.012); the mean percentage of on time without chorea increased from 26.6 percent to 59.2 percent (P = 0.006); the mean severity of off time decreased as assessed by both the Activities of Daily Living subscale of the Unified Parkinson's Disease Scale (P = 0.002) and the Schwab and England scale (P = 0.037). In contrast to the finding of Madrazo et al., however, the dosages of antiparkinsonian medications could not be decreased and postoperative morbidity was substantial. Despite cautious optimism, we conclude that the widespread use of this procedure outside of research centers is premature, since the improvement we found was slighter than in the previous cases.
...
PMID:Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. 274 74

We studied whether Parkinson's disease patients who had lost efficacy from pergolide (PERG) could benefit if transferred to bromocriptine (BCT) therapy. Using paired t-tests, we compared motor scores at baseline (when patients were still on PERG) and after 6 months of BCT therapy in 11 patients. No significant improvement occurred in any measure on BCT therapy (mean dose 33.6 mg/day), although patients remained stable. In 6 patients on whom "on/off" data were obtained, decreased "off" time and increased "on" time without chorea occurred, but these changes were not statistically significant. The side effect profile was similar with the 2 drugs.
...
PMID:Agonist substitution in advanced Parkinson's disease. 276 8

Twenty six consecutive patients with neuroleptic-induced Parkinson's syndrome (NIPS) are described. Their median age was 61 years, 60% were female, and most had received chronic neuroleptic medication for psychiatric indications. The clinical features were indistinguishable from idiopathic Parkinson's disease, except for the presence of co-existing orofacial chorea, limb dyskinesia or akathisia which provided an aetiological clue in 11 cases. Complete resolution of NIPS occurred in only two patients, one of whom later developed Parkinson's disease. Sixteen patients were treated with 300-1000 mg levodopa/benserazide for up to 4 years with few adverse effects but therapeutic response was disappointing.
...
PMID:Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. 290 Feb 93

The defects in execution of simple single arm movements at one joint, and of complex arm movements simultaneously or sequentially at two joints, in Parkinson's disease are analysed as a clue to the formal functions of the basal ganglia in human motor control. Slowness in execution of single movements, due to failure to scale the size of the initial electromyographic burst of activity in the agonist, is one characteristic abnormality. However, patients with Parkinson's disease are also shown to have added difficulty with complex motor tasks. When they attempt to undertake a hand 'squeeze' at the same time as an elbow 'flex', both movements are even slower. When they try to perform an elbow flex as quickly as possible after a hand squeeze with the same or opposite arms, the second movement is slowed and the interval between movements is prolonged. Similar movement abnormalities have been found in patients with Huntington's disease-even in those with chorea alone, and irrespective of drug therapy-and in a patient with an infarct involving the right supplementary motor area. These observations suggest that the basal ganglia in humans are required to set up the correct motor programmes to execute complex simultaneous and sequential movements. It is suggested that the basal ganglia, acting on a read-out of existing sensorimotor cortical activity, direct the premotor cortical areas to select the correct parameters of the motor programmes required for subsequent motor action.
...
PMID:What do the basal ganglia tell premotor cortical areas? 296 40

Investigation of motor function in a group of 17 patients with Huntington's disease reveals that, in addition to the chorea that many patients exhibit, defects in voluntary motor performance also are evident. Fast simple wrist flexion movements to 15 degrees or 60 degrees were slower, and individual movements showed greater variability than seen in normal subjects. This bradykinesia was most pronounced in those patients who were akinetic and rigid, but also was seen in those with chorea alone; bradykinesia was independent of the drug treatment that the patients were receiving (and was therefore not due to drug-induced parkinsonism). The electromyographic activity of the agonist muscles during such simple but slow movement differed from that seen in Parkinson's disease. The performance of complex movements revealed further deficits. Some patients were unable to combine two movements in a simultaneous or sequential movement task of squeezing the hand and flexing the elbow. Those who could perform these complex movements exhibited slowing of the velocity of the movement and prolongation of the interval between movements. These abnormalities were present in patients with chorea who were not taking neuroleptic drugs. It is argued that they represent an abnormality of motor programming of complex movements, over and above the defect in executing simple movements. The long latency stretch reflexes in wrist flexor muscles and flexor pollicis longus were reduced or absent, but this did not correlate with changes in motor performance, or with the reduced size of the early components of cortical sensory evoked potentials. Bradykinesia is thus shown to be an integral component of the motor disorder of Huntington's disease, in addition to the chorea. The coexistence of bradykinesia and chorea in this illness is compatible with current theories of the role of the basal ganglia in the control of movement.
...
PMID:The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. 296 29

The large-scale mail questionnaire is a useful tool in epidemiological investigation and will probably come into wider use in the search for an environmental cause of Parkinson's disease (PD). To determine the validity of mail questionnaires in patients with PD, we administered a 17-item questionnaire by in-person interview, as a standard, to 68 patients (and/or a relative when necessary) and compared the results with the same questionnaire mailed at least 1 month before or after the interview. Questions in three formats requested recall of the clinical course and past environmental factors. Each patient also completed a multiple-choice physical self-assessment (a modification of four items on the Columbia Scale) immediately before seeing the neurologist, who completed the same form after the examination. Percent of patients with zero discordance between mail and interview responses averaged 52% for the nine fill-in-a-year items, 53% for the three list-generation items. Kappa statistics for the five multiple-choice items, which each offered four choices, averaged 0.67 (range 0.40-0.89). Kappa for the physical examination items, each rated on a 0-3 scale, was finger-tap 0.12, gait 0.34, tremor 0.35, and chorea 0.20. Patients' ratings tended to be more severe than neurologists' ratings. We conclude that mail surveys in PD should either be avoided or rigorously pretested for validity.
...
PMID:Validity of a mailed epidemiological questionnaire and physical self-assessment in Parkinson's disease. 319 62

Tremor and drug-induced dyskinesia are major involuntary movements in Parkinson's disease. The rhythm of resting tremor is 4-6 cycles/s, driven by generators in the brain, and stabilized by reflex arcs involving the spinal cord, nerves and muscles. Its frequency is fixed: it is the same in proximal and distal muscles in each case and does not change in the course of amplitude reduction of tremor by levodopa injection. An approximate doubling of frequency occurs in action tremor which suggests a central mechanism liable to produce harmonics. In postural tremor as observed in the lower limbs while on standing, the frequency of grouped discharges falls into ranges of rhythm with either resting or action tremor. Levodopa-induced dyskinesia has a similar nature to chorea in both clinical observation and EMG. With EMG choreic discharges may appear concomitant with regular parkinsonian tremors in the same muscle, suggesting that the two are not opposites as expressions of dysfunction of the dopaminergic system.
...
PMID:Pathophysiology of involuntary movements in Parkinson's disease. 355 88

Long-acting levodopa/carbidopa combination (CR-4-Sinemet) was compared with traditional levodopa/carbidopa (Sinemet) open label in 20 patients with Parkinson's disease and "wearing-off" phenomena. After 4 to 6 weeks of therapy with CR-4-Sinemet, the number of daily doses of medication dropped significantly compared with traditional Sinemet, disability improved, and "on" time increased. In nine patients receiving CR-4-Sinemet for 3 months, the number of daily doses and the on time without chorea remained significantly improved. CR-4-Sinemet peaked in plasma after 2 hours, and moderately high levels remained at 4 hours after the dose. Side effects were similar between traditional Sinemet and CR-4 Sinemet.
...
PMID:Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet). 357 96

On a nearly zero protein diet, 11 patients with Parkinson's disease with the "on-off" effect demonstrated great sensitivity to levodopa (L-dopa)-carbidopa and reduced fluctuations. Eight patients required a 41% reduction in total L-dopa dosage and discontinuation of all adjuvant therapy to reduce the preponderance of chorea. On a high-protein diet, all patients were immobilized by bradykinesia for most of the day. A low-protein dietary regimen during the daytime offers an important technique for the control of fluctuations in patients with Parkinson's disease who are receiving L-dopa-carbidopa.
...
PMID:Influence of dietary protein on motor fluctuations in Parkinson's disease. 382 78


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>